XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Beginning Balance, shares outstanding (in shares) at Dec. 31, 2021   137,498      
Beginning Balance at Dec. 31, 2021 $ 196,953 $ 138 $ 256,347 $ (620) $ (58,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 24,397   24,397    
Issuance of common stock for the induced conversion of 2024 Convertible Notes (in shares)   1,512      
Issuance of common stock for the induced conversion of 2024 Convertible Notes 1,693 $ 1 1,692    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan (in shares)   1,077      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 14,050 $ 1 14,049    
Capped call transaction (69,120)   (69,120)    
Repurchase of common stock (in shares)   (4,933)      
Repurchase of common stock (200,002) $ (5) (199,997)    
Other comprehensive (loss) income (302)     (302)  
Net income 202,129       202,129
Ending Balance, shares outstanding (in shares) at Dec. 31, 2022   135,154      
Ending Balance at Dec. 31, 2022 169,798 $ 135 27,368 (922) 143,217
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 36,620   36,620    
Issuance of common stock for the induced conversion of 2024 Convertible Notes (in shares)   289      
Issuance of common stock for the induced conversion of 2024 Convertible Notes (126) $ 0 (126)    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan (in shares)   945      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 7,879 $ 2 7,877    
Repurchase of common stock (in shares)   (9,618)      
Repurchase of common stock (403,601) $ (10) (69,330)   (334,261)
Other comprehensive (loss) income (8,356)     (8,356)  
Net income 281,594       281,594
Ending Balance, shares outstanding (in shares) at Dec. 31, 2023   126,770      
Ending Balance at Dec. 31, 2023 83,808 $ 127 2,409 (9,278) 90,550
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 43,385   43,385    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan (in shares)   1,615      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 31,139 $ 1 31,138    
Repurchase of common stock (in shares)   (5,247)      
Repurchase of common stock (251,709) $ (5) (76,932)   (174,772)
Other comprehensive (loss) income 13,107     13,107  
Net income 444,091       444,091
Ending Balance, shares outstanding (in shares) at Dec. 31, 2024   123,138      
Ending Balance at Dec. 31, 2024 $ 363,821 $ 123 $ 0 $ 3,829 $ 359,869